Docencia
Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz. Madrid
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years After Starting Antiretroviral Therapy
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Antiretroviral Therapy for Prevention of HIV-1 Transmission
Dra. Concha Amador Prous. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. ESTUDIO PARTNER
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal. Madrid
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapy
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted proteaseinhibitor-based regimens for initial treatment of HIV infection: A systematic review andmeta-analysis of randomised trials
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care
Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis
Dr. Felix Gutiérrez. Departamento de Medicina Clínica. Hospital General Universitario.Elche
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Preven:on in Women
Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection
Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid
Ledipasvir Plus Sofosbuvir in Treatment- Naïve or-experienced Patients With Hepatitis C Genotype 5 Infection: An Open-Label, Phase 2 study Abergel A, et al. Lancet Infectious Diseases, 2016
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Switching from TDF to TAF in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: A randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. ENSAYO GS-US-292-0109
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estmated glomerular filtration rate: a prospective international cohort study
Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Dr. Félix Gutierrez. Departamento de Medicina Clínica. Hospital General Universitario. Elche
Withdrawing inactive NRTIs in HIV-1 sujects with suppressed viraemia: a randomized trial
Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona
Estudios ASTRAL 1, 2, 3 Y 4
Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in AfricaThe TEMPRANO ANRS 12136 Study GroupN Engl J Med. Volume 373(9):808-822. August 27, 2015
Dr. Antonio Rivero Román. Jefe de sección de Enfermedades Infecciosas.Hospital Universitario Reina Sofía. Córdoba
High-Dose Vitamin D and Calcium Attenuates Bone Loss with Antiretroviral Therapy Initiation: A Prospective, Randomized Placebo-Controlled Trial for Bone Health in HIV-Infected Individuals
Dr. Federico Pulido. Unidad de Infección VIH Hospital 12 de Octubre. Madrid
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phaseof a pragmatic open-label randomised trial
Dra. María Jesus Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid
